PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
PharmaTox-video med Geir Kjetil Sandve og Harald Eia
Apr. 6, 2022 7:01 AM
Harald Eia lurer på om det er sånn at man kjører masse data inn i datamaksinen, og så finner man at barnet får tannstein dersom mor brukte briller i svangerskapet. Geir Kjetil Sandve svarer.
-
PharmaTox-video med Kristina Gervin og Harald Eia
Mar. 30, 2022 8:49 AM
Da Kristina Gervin starter på det hun kaller en litt barnslig forklaring av epigenetikk, ber Harald Eia om den ikke-barnslige forklaringen. Han angrer seg umiddelbart.
-
We congratulate Eivind Ystrøm with the ERC Consolidator grant!
Mar. 28, 2022 7:26 PM
The PharmaTox associated professor Eivind Ystrøm has been awarded the ERC Consolidator grant. Congratulations!
-
PharmaTox-video med Eivind Ystrøm og Harald Eia
Mar. 23, 2022 6:55 AM
– Hvordan går du fram for å finne om det har en effekt på barna at mora tok mye smertestillende i svangerskapet? Om det er medisinbruk eller sårbare gener?, spør Harald Eia, og Eivind Ystrøm svarer.
-
Collaboration with McGill brings Vivian to Norway!
Mar. 17, 2022 1:48 PM
The Department of Epidemiology, Biostatistics, and Occupational Health at McGill University/ Professor Robert Platt is one of our international partners in the iAPOGEE INTPART project. Vivian has received an iAPOGEE Scholarship to come and work with us on the treatment of cardiovascular diseases in pregnancy. Below she presents herself.
